These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1283 related articles for article (PubMed ID: 23387478)
41. Investigating layer-by-layer chitosan-dextran sulfate-coated mesoporous silica as a pH-sensitive drug delivery system. Hooshyar MR; Raygan S; Mehdinavaz Aghdam R J Mater Sci Mater Med; 2024 Jun; 35(1):29. PubMed ID: 38884680 [TBL] [Abstract][Full Text] [Related]
42. Carriers for hydrophobic drug molecules: lipid-coated hollow mesoporous silica particles, and the influence of shape and size on encapsulation efficiency. Iqbal S; Schneider TK; Truong TT; Ulrich-Müller R; Nguyen PH; Ilyas S; Mathur S Nanoscale; 2024 Jun; 16(23):11274-11289. PubMed ID: 38787696 [TBL] [Abstract][Full Text] [Related]
43. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers. Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897 [TBL] [Abstract][Full Text] [Related]
44. Mesoporous silica nanoparticles: A multifunctional nano therapeutic system. Mai WX; Meng H Integr Biol (Camb); 2013 Jan; 5(1):19-28. PubMed ID: 23042147 [TBL] [Abstract][Full Text] [Related]
45. Re-examining the size/charge paradigm: differing in vivo characteristics of size- and charge-matched mesoporous silica nanoparticles. Townson JL; Lin YS; Agola JO; Carnes EC; Leong HS; Lewis JD; Haynes CL; Brinker CJ J Am Chem Soc; 2013 Oct; 135(43):16030-3. PubMed ID: 24107191 [TBL] [Abstract][Full Text] [Related]
46. Mesoporous silica nanoparticle-supported nanocarriers with enhanced drug loading, encapsulation stability, and targeting efficiency. Oh JY; Yang G; Choi E; Ryu JH Biomater Sci; 2022 Mar; 10(6):1448-1455. PubMed ID: 35229845 [TBL] [Abstract][Full Text] [Related]
47. Influence of Drug-Silica Electrostatic Interactions on Drug Release from Mesoporous Silica-Based Oral Delivery Systems. Hate SS; Reutzel-Edens SM; Taylor LS Mol Pharm; 2020 Sep; 17(9):3435-3446. PubMed ID: 32790416 [TBL] [Abstract][Full Text] [Related]
48. Functionalization of mesoporous silica nanoparticles with a cell-penetrating peptide to target mammalian sperm in vitro. Barkalina N; Jones C; Townley H; Coward K Nanomedicine (Lond); 2015 May; 10(10):1539-53. PubMed ID: 26008192 [TBL] [Abstract][Full Text] [Related]
49. pH- and temperature-responsive radially porous silica nanoparticles with high-capacity drug loading for controlled drug delivery. Choi Y; Kim J; Yu S; Hong S Nanotechnology; 2020 Aug; 31(33):335103. PubMed ID: 32369797 [TBL] [Abstract][Full Text] [Related]
50. A Comparison of Chitosan, Mesoporous Silica and Poly(lactic-co-glycolic) Acid Nanocarriers for Optimising Intestinal Uptake of Oral Protein Therapeutics. Wright L; Joyce P; Barnes TJ; Lundmark R; Bergström CAS; Hubert M; Prestidge CA J Pharm Sci; 2021 Jan; 110(1):217-227. PubMed ID: 32979363 [TBL] [Abstract][Full Text] [Related]
51. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles. Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245 [TBL] [Abstract][Full Text] [Related]
52. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system. Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540 [TBL] [Abstract][Full Text] [Related]
53. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents. Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791 [TBL] [Abstract][Full Text] [Related]
54. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research. Pattnaik S; Pathak K Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249 [TBL] [Abstract][Full Text] [Related]
55. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers. Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731 [TBL] [Abstract][Full Text] [Related]
56. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators. Yang Y; Zhang M; Song H; Yu C Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182 [TBL] [Abstract][Full Text] [Related]
57. Mesoporous silica nanoparticles as cutting-edge theranostics: Advancement from merely a carrier to tailor-made smart delivery platform. Kumar P; Tambe P; Paknikar KM; Gajbhiye V J Control Release; 2018 Oct; 287():35-57. PubMed ID: 30125637 [TBL] [Abstract][Full Text] [Related]
58. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs. Li T; Geng T; Md A; Banerjee P; Wang B Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109 [TBL] [Abstract][Full Text] [Related]
59. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. Meng H; Liong M; Xia T; Li Z; Ji Z; Zink JI; Nel AE ACS Nano; 2010 Aug; 4(8):4539-50. PubMed ID: 20731437 [TBL] [Abstract][Full Text] [Related]